Hydrophobicity‐enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells
Protein Science · 2023-12 · 32 (12)
DOI: 10.1002/pro.4819 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein Science, online erschienen am 21.11.2023. Verfasst von Alessio Incocciati und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Ellipticines, Antineoplastic Agents, Nanoparticles. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU, Sapienza University of Rome, SEED-PNR 2022, Charles University.
Abstract (Originalsprache)
Ferritin, a naturally occurring iron storage protein, has gained significant attention as a drug delivery platform due to its inherent biocompatibility and capacity to encapsulate therapeutic agents. In this study, we successfully genetically engineered human H ferritin by incorporating 4 or 6 tryptophan residues per subunit, strategically oriented towards the inner cavity of the nanoparticle. This modification aimed to enhance the encapsulation of hydrophobic drugs into the ferritin cage. Comprehensive characterization of the mutants revealed that only the variant carrying four tryptophan substitutions per subunit retained the ability to disassemble and reassemble properly. As a proof of concept, we evaluated the loading capacity of this mutant with ellipticine, a natural hydrophobic indole alkaloid with multimodal anticancer activity. Our data demonstrated that this specific mutant exhibited significantly higher efficiency in loading ellipticine compared to human H ferritin. Furthermore, to evaluate the versatility of this hydrophobicity‐enhanced ferritin nanoparticle as a drug carrier, we conducted a comparative study by also encapsulating doxorubicin, a commonly used anticancer drug. Subsequently, we tested both ellipticine and doxorubicin‐loaded nanoparticles on a promyelocytic leukemia cell line, demonstrating efficient uptake by these cells and resulting in the expected cytotoxic effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy.
- Department of Biochemical Sciences, Faculty of Pharmacy in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
- Center of Life Nano- and Neuro-Science, Italian Institute of Technology, Rome, Italy.
- Core Facilities, Istituto Superiore di Sanità, Rome, Italy.
ORCID-Profile: Alessio Incocciati, Alberto Macone
Förderung
- NextGenerationEU
- Sapienza University of Rome, SEED-PNR 2022
- Charles University
- Sapienza Università di Roma
- Univerzita Karlova v Praze
Zitieren
APA
Incocciati, A., Kubeš, J., Piacentini, R., Cappelletti, C., Botta, S., Bertuccini, L., Šimůnek, T., Boffi, A., Macone, A., & Bonamore, A. (2023). Hydrophobicity‐enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells. Protein Science, 32(12). https://doi.org/10.1002/pro.4819
Vancouver
Incocciati A, Kubeš J, Piacentini R, Cappelletti C, Botta S, Bertuccini L, et al. Hydrophobicity‐enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells. Protein Science. 2023;32(12). doi:10.1002/pro.4819
BibTeX
@article{Incocciati2023,
author = {Incocciati, Alessio and Kubeš, Jan and Piacentini, Roberta and Cappelletti, Chiara and Botta, Sofia and Bertuccini, Lucia and Šimůnek, Tomáš and Boffi, Alberto and Macone, Alberto and Bonamore, Alessandra},
title = {Hydrophobicity‐enhanced ferritin nanoparticles for efficient encapsulation and targeted delivery of hydrophobic drugs to tumor cells},
journal = {Protein Science},
year = {2023},
volume = {32},
number = {12},
doi = {10.1002/pro.4819}
}
EUVIMED